VOLITIONRX LTD — Director's Dealing 2021

Mar 29, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2021-03-25

Reporting Person: Brudnick Richard (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-25	Common Stock	A	15000	—	Acquired	15000	Direct

Footnotes

F1: Mr. Brudnick received restricted stock units subject to a 2-year vesting schedule, vesting as to 7,500 units on each of 03/25/22 and 03/25/23, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.